Helen Louise Collins Imara Inc. (IMRA) insider trading activity

Helen Louise Collins is CHIEF MEDICAL OFFICER of IMARA Inc.. Currently has a direct ownership of 0 shares of IMRA, which is worth approximately $0. The most recent transaction as insider was on Oct 18, 2024, when has been sold 816 shares (Common Stock) at a price of $30.0 per share, resulting in proceeds of $24,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Helen Louise Collins Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 18 2024	SELL Open market or private sale	$24,480 $30.0 p/Share	816 Reduced 100.0%	0 Common Stock
Oct 18 2024	BUY Exercise of conversion of derivative security	$2,023 $2.48 p/Share	816 Added 50.0%	816 Common Stock
Apr 11 2024	SELL Open market or private sale	$501,400 $25.07 p/Share	20,000 Reduced 100.0%	0 Common Stock
Apr 11 2024	BUY Exercise of conversion of derivative security	$49,600 $2.48 p/Share	20,000 Added 50.0%	20,000 Common Stock

Also insider at

FPRX

FIVE PRIME THERAPEUTICS, INC.

EVP and Chief Medical Officer

KURA

Kura Oncology, Inc. Healthcare

IOBT

IO Biotech, Inc. Healthcare

HLC